Tata Steel Trials Canadian Iron Ore for Future Shortages
Tata Steel books first bulk shipment from Canada to hedge against captive mine expiries in 2030. A strategic move to secure raw material supply and explore future options. Read more.
Category : Search result: semaglutide patent expiry
Meesho shares fall 5% post lock-in expiry, brokers positive
Meesho's shares fell 5% after a lock-in period ended, releasing 110 million shares. Major brokerages like UBS remain optimistic, citing strong growth potential in India's mass market. Read the full analysis.
Meesho stock falls 5% after IPO lock-in expiry
Meesho shares fell 5% as a 1-month lock-in for pre-IPO investors ended, making 109.9 million shares eligible for trade. Analysts cite increased supply and high valuations for the pressure.
Natco Pharma Sues to Revoke Novo Nordisk's Semaglutide Patent
Natco Pharma files suit in Delhi High Court seeking revocation of Novo Nordisk's patent on diabetes drug semaglutide. Court issues notice, hearing set for Feb 5. Indian pharma race for generic Ozempic heats up.
$45B IPO Lock-In Expiry for 96 Firms Jan-Apr
A massive $45 billion worth of IPO lock-in periods are set to expire for 96 Indian companies between Jan 6 and Apr 30. Learn which stocks are affected and how it could impact prices.
$45 Billion IPO Lock-In Expiry May Trigger Volatility
A massive $45 billion worth of IPO lock-in expiries are set to hit Indian markets in coming months, potentially triggering volatility. Nuvama warns of pressure on specific stocks. Read the full analysis.
KGMU-IIT Kanpur get patent for wearable breast sensor
SIB SHInE at KGMU, with IIT-Kanpur, patents a wearable sensor for early breast abnormality detection. A breakthrough in med-tech innovation. Read about the collaborative triumph.
PU's Robotic Lawn Mower Gets Patent for Grass Printing
Panjab University's Design Innovation Centre receives an Indian patent for its 'Grass Printer' robot. This autonomous machine can cut grass at varying heights to print messages, symbols, and intricate designs on large lawns, revolutionizing automated land
Why Indian Drug Makers Challenge Global Patents
Explore the high-stakes legal battles between Indian generic manufacturers and global pharma giants. Understand the impact on drug prices, accessibility, and the evolving IP landscape in India.
Natco Files to Revoke Novo Nordisk's Wegovy Patent in India
Hyderabad's Natco Pharma petitions Delhi High Court to revoke Novo Nordisk's semaglutide patent. The legal battle shapes India's future weight-loss drug market as 2026 patent expiry nears. Read more.
Ex-Minister Prabhu Lal Saini Patents 3 Date Palm Varieties
Former Rajasthan agriculture minister Prabhu Lal Saini secures patents for three indigenous date palm varieties, ST-1, ST-2, and ST-3, boosting local cultivation. Discover his 10-year research journey.
Novo Nordisk launches Wegovy weight-loss pill in US
Novo Nordisk launches oral Wegovy weight-loss drug in the US, priced at $299. The pill, approved in Dec 2025, aims to regain market share from rival Eli Lilly. UK approval expected end-2026.
Novo Nordisk: Wegovy Price Cut to Boost India Obesity Therapy 5-7x
Novo Nordisk expects India's obesity drug market to grow rapidly after a 37% Wegovy price cut, mirroring insulin uptake. Generic competition looms with a Rs 5000-crore opportunity.
PAU Gets Patent for Rodent Contraceptive Bait
Punjab Agricultural University patents a groundbreaking contraceptive bait for rodents, offering a humane and effective solution to protect crops and public health. Learn about this innovative pest control method.
Generic Semaglutide to Create Rs 50,000 Cr Market
The patent expiry of semaglutide drugs will create a massive Rs 50 billion+ revenue opportunity for generic makers in India and globally over the next 12-15 months, boosting diabetes treatment access. Read the full analysis.
Generic Semaglutide to Create Rs 50bn+ Revenue Opportunity
Patent expiry of semaglutide drugs will create a Rs 50+ billion revenue chance for generic pharma firms in 12-15 months. Prices may drop up to 75%, boosting patient access. Read the full analysis.
Semaglutide Patent Expiry Creates Rs 50,000 Cr Opportunity
The patent expiry of Novo Nordisk's blockbuster drug semaglutide (Ozempic, Wegovy) opens a massive Rs 50,000+ crore market for Indian generic drugmakers, a new report reveals.
Heart Protection from Semaglutide: Key Findings for India
New data shows semaglutide reduces major heart events by 20%, independent of weight loss. This breakthrough offers new hope for India's early-onset heart disease patients. Learn more.
Weight-loss drugs poised for takeoff, cancer care expands in 2026
GLP-1 weight-loss drugs, despite limited uptake, topped India's pharma sales by value in 2025. With generics and new approvals coming, 2026 promises wider access. Plus, government plans 200+ Day Care Cancer Centres. Read the full analysis.
Why the Safety Pin Has a Hole: A 175-Year-Old Design Secret
Discover the engineering marvel behind the tiny hole in every safety pin. From Walter Hunt's 1849 patent to modern uses, learn how this simple feature ensures durability and function.
Canada's Undocumented Immigrant Crisis: 2 Million by 2026
Canada faces a surge in undocumented immigrants as work permits expire. With nearly half from India, expert Kanwar Seirah warns of social impact. Learn the critical details.
Tesla Loses Top EV Spot to BYD After 2025 Sales Decline
Tesla's global EV crown slips to China's BYD after a 9% delivery drop in 2025. Intense competition and expiring US tax credits hit sales. Can Musk's robotaxi and robotics pivot revive fortunes? Read the full analysis.
IIT Jodhpur files record 86 IPRs in 2025
IIT Jodhpur achieves a milestone with 86 IPR filings in 2025, marking a 150% growth. The patents focus on affordable, sustainable tech for national priorities. Discover the institute's innovation drive.
Indian Pharma Firms Eye Licensing Deals for Obesity Drugs
As patents expire, Indian drugmakers like Lupin and Ajanta Pharma are forging licensing and distribution deals for GLP-1 obesity drugs. The market is set for explosive growth. Explore the key partnerships and market dynamics.
MGU Kottayam gets patent for AI driver fatigue detection system
Mahatma Gandhi University patents an AI-powered drowsiness detection system developed by Prof. Pushpalatha K P & Vineetha Vijayan. It aims to slash road accidents via real-time alerts. Read more.
42 kg Undated Bread Seized from Noida Fast Food Outlet
Food safety officials in Noida seized over 42 kg of Italian bread lacking expiry dates from a major sandwich chain. The crackdown is part of pre-New Year inspections across GB Nagar. Read for details.
MSU's Modular Toddler Play Station Wins Design Patent
Maharaja Sayajirao University's innovative 'Play Station for Toddlers' transforms into regular furniture. This modular, Montessori-inspired design promotes learning and safety. Read more about this patented innovation.
Market Cautious on F&O Expiry, Gold & Bitcoin Correct
Indian stock markets consolidate amid F&O expiry and profit booking. Gold prices correct sharply by ₹5,000, Bitcoin slips ₹55,000. Experts share Nifty, Bank Nifty outlook and 8 stock picks for today.
Indian Markets to Consolidate in Final 2025 Trading Sessions
Indian stock markets are set to end 2025 with double-digit gains despite a tough year. With two sessions left, experts predict consolidation and advise selective, value-focused investing for 2026.
Nifty, Sensex Flat in Thin Trade; Expiry May Spike Volatility
Indian equity benchmarks opened flat on Thursday with low volumes as the year draws to a close. Analysts warn of potential volatility due to the monthly F&O expiry. Key sectors and stocks in focus.
Page 1 of 4